Use of vanilloids for the prevention of lesions due to herpes simplex infections
US5461075A · kind A · utility
10Cited by
13References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 1991 |
| Grant date | Oct 24, 1995 |
| Priority date | — |
| Expiry date | Mar 14, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/165
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of preventing lesions due to herpes simplex infections in humans and lower animals by treatment with natural and synthetic vanilloid compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.